Please provide your email address to receive an email when new articles are posted on . Endovascular therapy (EVT) for post-thrombotic syndrome improved symptom severity and patient-reported quality ...
(HealthDay News) — The addition of pharmacomechanical thrombolysis does not reduce the risk of post-thrombotic syndrome among patients with acute proximal deep vein thrombosis, according to a study ...
Stents Can Ease Long-Term Symptoms Of Deep Vein Thrombosis, Trial Shows By Dennis Thompson HealthDay ReporterTUESDAY, April 14, 2026 (HealthDay News) — A common and painful complication of deep vein ...
Purpose: Deep-vein thrombosis (DVT) and pulmonary embolism (PE) are associated with major morbidity and mortality, with their burden often extending to longer-term complications such as event ...
TCT 718: All Through the Upper Limbs Completely Percutaneously: Aortic Balloon Valvuloplasty, Insertion of the Impella CP and Complex Coronary Intervention Receive the the latest news, research, and ...
In a recent study published on the preprint server medRxiv*, researchers aimed to better understand the population-level thrombotic risks post COVID-19 vaccination with both the ChAdOx1-S and BNT162b2 ...
TORONTO (April 13, 2026)—The results of a prominent, National Institutes of Health (NIH) sponsored study into the treatment of post-thrombotic syndrome (PTS) following deep vein thrombosis (DVT) ...
Patients with thrombotic antiphospholipid syndrome are better treated with a vitamin K antagonist, such as warfarin, rather than a direct oral anticoagulant (DOAC), a new systematic review and ...
Please provide your email address to receive an email when new articles are posted on . CHICAGO — In patients with thrombotic antiphospholipid syndrome, vitamin K antagonists were linked to lower odds ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results